Sign in or create an account to add this stock to your watchlist.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions. The company's services also enable customers to recover improper payments; prevent future improper payments; reduce fraud, waste, and abuse; improve outcomes and increase retention; and ensure regulatory compliance. It serves state Medicaid programs, commercial health plans, federal government health agencies, government and private employers, children's health insurance programs, and other healthcare payers and sponsors. The company was founded in 1974 and is headquartered in Irving, Texas.
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:HMSY
CUSIP40425J10
Phone214-453-3000
Debt
Debt-to-Equity Ratio0.39
Current Ratio4.14
Quick Ratio4.14
Price-To-Earnings
Trailing P/E Ratio49.44
Forward P/E Ratio32.72
P/E Growth2.98
Sales & Book Value
Annual Sales$521.21 million
Price / Sales3.40
Cash Flow$1.0593 per share
Price / Cash20.08
Book Value$7.21 per share
Price / Book2.95
Profitability
EPS (Most Recent Fiscal Year)$0.43
Net Income$40.05 million
Net Margins8.20%
Return on Equity8.01%
Return on Assets4.95%
Miscellaneous
Employees2,500
Outstanding Shares83,220,000
HMS (NASDAQ:HMSY) Frequently Asked Questions
What is HMS's stock symbol?
HMS trades on the NASDAQ under the ticker symbol "HMSY."
How will HMS's stock buyback program work?
HMS declared that its Board of Directors has authorized a stock buyback plan on Saturday, November 4th 2017, which authorizes the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its shares are undervalued.
How were HMS's earnings last quarter?
HMS Holdings (NASDAQ:HMSY) posted its quarterly earnings data on Friday, May, 4th. The business services provider reported $0.22 EPS for the quarter, beating the Zacks' consensus estimate of $0.15 by $0.07. The business services provider earned $141.40 million during the quarter, compared to analyst estimates of $130.10 million. HMS had a net margin of 8.20% and a return on equity of 8.01%. The business's revenue for the quarter was up 23.5% on a year-over-year basis. During the same period last year, the firm earned $0.14 EPS. View HMS's Earnings History.
When is HMS's next earnings date?
What price target have analysts set for HMSY?
8 brokers have issued twelve-month target prices for HMS's stock. Their forecasts range from $17.00 to $23.00. On average, they expect HMS's stock price to reach $19.50 in the next year. View Analyst Ratings for HMS.
What are Wall Street analysts saying about HMS stock?
Here are some recent quotes from research analysts about HMS stock:
- 1. According to Zacks Investment Research, "HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. " (2/28/2018)
- 2. Cantor Fitzgerald analysts commented, "Solid 4Q17 results. On February 23, HMSY reported solid 4Q17 results. Revenue of $148.5 million came in ahead of FactSet consensus of $136.8 million and our estimate of $139.6 million. Revenue growth was broad-based, with double digit growth in both COB and PI. Following a timing related decline in 3Q17, COB revenue of $105.7 million grew 17.4% q/q. About $6-$8 million of COB revenue is attributable to 3Q17. PI revenue of $26.8 million grew 12.2% q/ q and benefited from the implementation of enhanced analytics. PI performance seems to be improving. Eliza revenue of $12.9 million grew 30% q/q as Eliza’s revenue tends to be back-end loaded, with 3Q and 4Q being the strongest. As year end approaches, clients seek to maximize Medicare Star ratings and HEDIS measures. Management expects Eliza to contribute meaningfully to revenue growth in 2018. Adjusted EPS of $0.49 included a $0.25 non-cash tax benefit." (2/23/2018)
Who are some of HMS's key competitors?
Some companies that are related to HMS include athenahealth (ATHN), FICO (FICO), HealthEquity (HQY), Stamps.com (STMP), Conduent (CNDT), Maximus (MMS), TriNet (TNET), Etsy (ETSY), Ritchie Bros. Auctioneers (RBA), Cotiviti (COTV), Sotheby's (BID), Envestnet (ENV), WNS Global Services (WNS), EXL (EXLS) and Wageworks (WAGE).
Who are HMS's key executives?
HMS's management team includes the folowing people:
- Mr. William C. Lucia FLMI, Chairman, Pres & CEO (Age 60)
- Mr. Jeffrey S. Sherman, Exec. VP, CFO & Treasurer (Age 52)
- Ms. Semone Wagner Neuman, Exec. VP of Operations & Information Technology (Age 54)
- Ms. Meredith W. Bjorck, Exec. VP, Gen. Counsel & Corp. Sec. (Age 42)
- Mr. Douglas M. Williams Jr., Pres of Markets & Product (Age 59)
Has HMS been receiving favorable news coverage?
Media coverage about HMSY stock has trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. HMS earned a coverage optimism score of 0.01 on Accern's scale. They also assigned media headlines about the business services provider an impact score of 44.49 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are HMS's major shareholders?
HMS's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.01%), VAN BERKOM & ASSOCIATES INC. (5.67%), Van Berkom & Associates Inc. (5.65%), Dimensional Fund Advisors LP (3.99%), Stephens Investment Management Group LLC (1.92%) and Millennium Management LLC (1.55%). Company insiders that own HMS stock include Bart M Schwartz, Cynthia Nustad, Douglas M Williams, Richard H Stowe, Robert Becker, Robert M Holster, Semone Neuman and William C Lucia. View Institutional Ownership Trends for HMS.
Which institutional investors are selling HMS stock?
HMSY stock was sold by a variety of institutional investors in the last quarter, including Stephens Investment Management Group LLC, Victory Capital Management Inc., Thrivent Financial for Lutherans, JPMorgan Chase & Co., HCSF Management LLC, Comerica Bank, Prudential Financial Inc. and Engineers Gate Manager LP. Company insiders that have sold HMS company stock in the last year include Cynthia Nustad, Douglas M Williams, Semone Neuman and William C Lucia. View Insider Buying and Selling for HMS.
Which institutional investors are buying HMS stock?
HMSY stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Van Berkom & Associates Inc., Massachusetts Financial Services Co. MA, Eagle Boston Investment Management Inc., Carillon Tower Advisers Inc., Tygh Capital Management Inc., Wells Fargo & Company MN and Citadel Advisors LLC. Company insiders that have bought HMS stock in the last two years include Bart M Schwartz and Robert Becker. View Insider Buying and Selling for HMS.
How do I buy shares of HMS?
Shares of HMSY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HMS's stock price today?
One share of HMSY stock can currently be purchased for approximately $21.27.
How big of a company is HMS?
HMS has a market capitalization of $1.77 billion and generates $521.21 million in revenue each year. The business services provider earns $40.05 million in net income (profit) each year or $0.43 on an earnings per share basis. HMS employs 2,500 workers across the globe.
How can I contact HMS?
HMS's mailing address is 5615 High Point Drive, Irving TX, 75038. The business services provider can be reached via phone at 214-453-3000 or via email at [email protected]
MarketBeat Community Rating for HMS (HMSY)
MarketBeat's community ratings are surveys of what our community members think about HMS and other stocks. Vote "Outperform" if you believe HMSY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HMSY will underperform the S&P 500 over the long term. You may vote once every thirty days.
HMS (NASDAQ:HMSY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for HMS in the last 12 months. Their average twelve-month price target is $19.50, suggesting that the stock has a possible downside of 8.32%. The high price target for HMSY is $23.00 and the low price target for HMSY is $17.00. There are currently 3 hold ratings, 3 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.88 | 2.88 | 2.80 | 2.88 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
2 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
2 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
2 Strong Buy Rating(s) |
| Consensus Price Target: | $19.50 | $19.50 | $20.1875 | $20.2143 |
| Price Target Upside: | 8.32% downside | 19.12% upside | 18.19% upside | 25.40% upside |
HMS (NASDAQ:HMSY) Consensus Price Target History
HMS (NASDAQ:HMSY) Analyst Ratings History
Show:
(Data available from 5/21/2016 forward)
HMS (NASDAQ:HMSY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
HMS (NASDAQ HMSY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.54%
Institutional Ownership Percentage: 98.02%
HMS (NASDAQ HMSY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/27/2017 | William C Lucia | Chairman | Sell | 29,894 | $20.00 | $597,880.00 | 222,745 |  |
| 8/31/2017 | Cynthia Nustad | EVP | Sell | 22,907 | $17.64 | $404,079.48 | 73,877 | |
| 8/28/2017 | Semone Neuman | EVP | Sell | 20,734 | $17.68 | $366,577.12 | 96,722 | |
| 8/9/2017 | Douglas M Williams | Insider | Sell | 13,140 | $17.78 | $233,629.20 | 121,264 | |
| 6/12/2017 | Bart M Schwartz | Director | Buy | 1,500 | $19.28 | $28,920.00 | 46,868 | |
| 6/9/2017 | Semone Neuman | EVP | Sell | 14,546 | $19.00 | $276,374.00 | 122,685 | |
| 9/26/2016 | William C Lucia | CEO | Sell | 45,280 | $22.09 | $1,000,235.20 | 194,982 | |
| 9/14/2016 | Robert Becker | Director | Buy | 5,000 | $21.96 | $109,800.00 | 11,701 | |
| 6/21/2016 | William C Lucia | CEO | Sell | 152,025 | $17.75 | $2,698,443.75 | 205,918 | |
| 6/20/2016 | William C Lucia | CEO | Sell | 60,356 | $18.00 | $1,086,408.00 | 205,918 | |
| 6/8/2016 | Richard H Stowe | Director | Sell | 20,000 | $18.11 | $362,200.00 | 67,818 | |
| 6/7/2016 | Cynthia Nustad | EVP | Sell | 10,995 | $17.79 | $195,601.05 | 93,316 | |
| 6/1/2016 | Robert M Holster | Director | Sell | 20,000 | $17.58 | $351,600.00 | 102,188 | |
| 6/1/2016 | Semone Neuman | EVP | Sell | 5,124 | $17.60 | $90,182.40 | 106,200 | |
| 3/8/2016 | Semone Neuman | EVP | Sell | 7,992 | $14.25 | $113,886.00 | 113,254 | |
| 3/1/2016 | Robert M Holster | Director | Sell | 100,000 | $13.52 | $1,352,000.00 | 122,188 | |
| 12/9/2015 | Robert M Holster | Director | Sell | 20,000 | $12.68 | $253,600.00 | 181,188 | |
| 11/23/2015 | Richard H Stowe | Director | Sell | 30,000 | $11.47 | $344,100.00 | 84,253 | |
| 11/18/2015 | Semone Neuman | EVP | Sell | 1,454 | $11.79 | $17,142.66 | 89,534 | |
| 11/11/2015 | Robert M. Holster | Director | Sell | 16,999 | $11.19 | $190,218.81 | 190,188 | |
| 8/13/2015 | Jeffrey Scott Sherman | CFO | Buy | 10,760 | $9.30 | $100,068.00 | | |
| 8/12/2015 | Eugene V Defelice | EVP | Buy | 2,000 | $8.79 | $17,580.00 | | |
| 7/10/2015 | Robert M Holster | Director | Sell | 7,000 | $16.00 | $112,000.00 | | |
| 6/12/2015 | Robert M Holster | Director | Sell | 7,000 | $17.56 | $122,920.00 | | |
| 5/18/2015 | Semone Wagner | EVP | Sell | 6,477 | $16.68 | $108,036.36 | | |
| 4/21/2015 | Robert M Holster | Director | Sell | 3,000 | $16.00 | $48,000.00 | | |
| 1/9/2015 | Robert M Holster | Director | Sell | 7,000 | $21.06 | $147,420.00 | | |
| 12/15/2014 | William C Lucia | CEO | Sell | 13,902 | $20.20 | $280,820.40 | | |
| 12/12/2014 | Robert M Holster | Director | Sell | 7,000 | $20.93 | $146,510.00 | | |
| 12/8/2014 | Ellen A Rudnick | Director | Sell | 10,000 | $22.46 | $224,600.00 | | |
| 11/28/2014 | Ellen A Rudnick | Director | Sell | 35,000 | $21.10 | $738,500.00 | | |
| 11/17/2014 | William C Lucia | CEO | Sell | 13,858 | $21.24 | $294,343.92 | | |
| 9/15/2014 | William C Lucia | CEO | Sell | 13,693 | $20.71 | $283,582.03 | | |
| 8/21/2014 | William F Miller III | Director | Sell | 25,000 | $23.03 | $575,750.00 | | |
| 5/19/2014 | Bart Schwartz | Director | Buy | 1,500 | $17.29 | $25,935.00 | 20,623 | |
| 5/19/2014 | Eugene Defelice | EVP | Buy | 1,000 | $17.29 | $17,290.00 | 10,980 | |
| 5/15/2014 | Craig Callen | Director | Buy | 3,000 | $17.39 | $52,170.00 | 10,530 | |
| 1/17/2014 | Robert Holster | Director | Sell | 5,000 | $25.83 | $129,150.00 | 216,543 | |
| 1/15/2014 | William Lucia | CEO | Sell | 20,000 | $25.02 | $500,400.00 | 305,426 | |
| 1/14/2014 | Robert Holster | Director | Sell | 10,000 | $24.00 | $240,000.00 | 218,543 | |
| 12/5/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $22.32 | $267,840.00 | 195,526 | |
| 11/8/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $22.00 | $264,000.00 | 207,526 | |
| 10/4/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $22.00 | $264,000.00 | 219,526 | |
| 9/5/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $24.21 | $290,520.00 | | |
| 8/1/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $24.30 | $291,600.00 | | |
| 7/5/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $23.26 | $279,120.00 | | |
| 6/12/2013 | William F Miller III | Director | Sell | 3,000 | $22.53 | $67,590.00 | | |
| 6/6/2013 | Christina Dragonetti | Insider | Sell | 12,000 | $24.03 | $288,360.00 | | |
| 3/4/2013 | Andrea Benko | EVP | Sell | 1,449 | $29.48 | $42,716.52 | | |
(Data available from 1/1/2013 forward)
HMS (NASDAQ HMSY) News Headlines
| Source: |
|
HMS (NASDAQ:HMSY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
HMS (NASDAQ:HMSY) Income Statement, Balance Sheet and Cash Flow Statement
HMS (NASDAQ HMSY) Stock Chart for Monday, May, 21, 2018
Loading chart…
